Search Results for "1"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for 1. Results 1331 to 1340 of 2603 total matches.

Cardiovascular Effects of Some Antidiabetic Drugs

   
The Medical Letter on Drugs and Therapeutics • Aug 14, 2017  (Issue 1527)
diabetes.1 Recent findings that some of the newer second-line drugs for type 2 diabetes ...
...
Med Lett Drugs Ther. 2017 Aug 14;59(1527):136-8 |  Show IntroductionHide Introduction

Antibacterial Drugs for Lyme Disease

   
The Medical Letter on Drugs and Therapeutics • May 17, 2021  (Issue 1624)
is also transmitted by I. scapularis, has been shown to cause a similar illness in the upper Midwest.1-3 ...
Lyme disease in the US is caused by the spirochete Borrelia burgdorferi, which is transmitted to humans by Ixodes scapularis (blacklegged [deer] tick) and I. pacificus (western blacklegged tick). Most cases of Lyme disease occur in late spring and early summer in northeastern and mid-Atlantic states, the upper Midwest, and in northern California. B. mayonii, which is also transmitted by I. scapularis, has been shown to cause a similar illness in the upper Midwest.
Med Lett Drugs Ther. 2021 May 17;63(1624):73-5 |  Show IntroductionHide Introduction

Drugs for Chronic Insomnia

   
The Medical Letter on Drugs and Therapeutics • Jan 09, 2023  (Issue 1667)
, pharmacologic treatment should be added.1-3 BENZODIAZEPINE RECEPTOR AGONISTS — Eszopiclone (Lunesta ...
Cognitive behavioral therapy for insomnia (CBT-I) is recommended for initial treatment of chronic insomnia. CBT-I includes stimulus control, sleep education and hygiene, sleep restriction, relaxation training, and cognitive therapy. When CBT-I alone is not effective, pharmacologic treatment should be added.
Med Lett Drugs Ther. 2023 Jan 9;65(1667):1-6   doi:10.58347/tml.2023.1667a |  Show IntroductionHide Introduction

Influenza Vaccine for 2024-2025

   
The Medical Letter on Drugs and Therapeutics • Sep 16, 2024  (Issue 1711)
influenza A and B viruses is recommended for everyone ≥6 months old without a contraindication.1 ...
Annual vaccination in the US against influenza A and B viruses is recommended for everyone ≥6 months old without a contraindication. Influenza vaccines available in the US for the 2024-2025 season are listed in Table 2.
Med Lett Drugs Ther. 2024 Sep 16;66(1711):145-50   doi:10.58347/tml.2024.1711a |  Show IntroductionHide Introduction

In Brief: Non-Inferiority Trials

   
The Medical Letter on Drugs and Therapeutics • Jan 10, 2011  (Issue 1355)
effective) than the control in achieving the primary outcome.1,2 Non-inferiority trials are appropriate ...
Several Medical Letter readers have asked about the meaning of non-inferiority trials. A non-inferiority trial is a comparison with an active control to determine whether the difference in response between the new drug and the active control is small enough (less than some pre-specified margin) to demonstrate that the new treatment is not less effective (or is only slightly less effective) than the control in achieving the primary outcome.1,2 Non-inferiority trials are appropriate when a proven effective treatment already exists and assigning some patients to a placebo group would be unethical...
Med Lett Drugs Ther. 2011 Jan 10;53(1355):1 |  Show IntroductionHide Introduction

In Brief: PCV13 for Adults 65 Years and Older

   
The Medical Letter on Drugs and Therapeutics • Oct 13, 2014  (Issue 1453)
pneumococcal polysaccharide vaccine (PPSV23; Pneumovax 23), for all adults ≥65 years old.1 An unpublished ...
The US Advisory Committee on Immunization Practices (ACIP) now recommends routine immunization with 13-valent pneumococcal conjugate vaccine (PCV13; Prevnar 13), in addition to the 23-valent pneumococcal polysaccharide vaccine (PPSV23; Pneumovax 23), for all adults ≥65 years old.1An unpublished, randomized, double-blind trial (CAPiTA) in about 85,000 adults ≥65 years old found that vaccination with PCV13 reduced first episodes of vaccine-type community-acquired pneumonia and invasive pneumococcal disease by 46% and 75%, respectively, compared to placebo.2Adults ≥65 years old who...
Med Lett Drugs Ther. 2014 Oct 13;56(1453):102 |  Show IntroductionHide Introduction

Addendum: Bupropion Safety in Pregnancy

   
The Medical Letter on Drugs and Therapeutics • Apr 01, 2024  (Issue 1699)
Addendum: Bupropion Safety in Pregnancy Volume 66 (Issue 1699) April 1, 2024 Our December 11 ...
Our December 11, 2023 article on Drugs for Depression included a single sentence on the safety of bupropion use during pregnancy: "The safety of bupropion during pregnancy has not been established; data from a bupropion pregnancy registry suggested a possible increase in cardiac malformations." A reader asked us to provide more information.
Med Lett Drugs Ther. 2024 Apr 1;66(1699):56   doi:10.58347/tml.2024.1699c |  Show IntroductionHide Introduction

In Brief: Esomeprazole Strontium

   
The Medical Letter on Drugs and Therapeutics • Jul 21, 2014  (Issue 1447)
data in those popu- Table 1. Oral Proton Pump Inhibitors Drug Usual Dosage1,2 Cost3 Dexlansoprazole ...
The FDA has approved the proton pump inhibitor (PPI) esomeprazole strontium for use in adults for the same indications as esomeprazole magnesium (Nexium): treatment of gastroesophageal reflux disease (GERD), prevention of NSAID-induced gastric ulcers, eradication of Helicobacter pylori, and treatment of pathological hypersecretory conditions. It was first marketed in December 2013 as a branded drug (Esomeprazole Strontium) and a month later as a generic drug.Strontium is incorporated into bone. It is not recommended for use in children or during pregnancy because of the absence of safety data...
Med Lett Drugs Ther. 2014 Jul 21;56(1447):64 |  Show IntroductionHide Introduction

In Brief: New Polio Vaccination Guidance for Travelers

   
The Medical Letter on Drugs and Therapeutics • Sep 01, 2014  (Issue 1450)
Letter® on Drugs and Therapeutics Objective Drug Reviews Since 1959 Volume 56 September 1, 2014 ...
Wild poliovirus has circulated during the previous 12 months in Cameroon, Equatorial Guinea, Ethiopia, Iraq, Israel (also the West Bank and Gaza), Somalia, and Syria, as well as in those countries where polio is still endemic (Afghanistan, Nigeria, and Pakistan). The World Health Organization (WHO) has declared a public health emergency related to the possible spread of polio from affected countries. In response, the Centers for Disease Control and Prevention (CDC) has issued interim guidance for US residents planning travel to and from these countries.Vaccine Recommendations – All travelers...
Med Lett Drugs Ther. 2014 Sep 1;56(1450):84 |  Show IntroductionHide Introduction

ColciGel - A Homeopathic Colchicine Gel for Gout

   
The Medical Letter on Drugs and Therapeutics • Jan 04, 2016  (Issue 1485)
consist of very large dilutions of "proven" substances. Serial dilutions of 1:10 are designated ...
Homeopathic drugs characteristically consist of very large dilutions of "proven" substances. Serial dilutions of 1:10 are designated by the Roman numeral X. ColciGel (Gensco), a prescription homeopathic gel containing a 10,000-fold dilution of colchicine (colchicinum 4X), is now being marketed for topical treatment and prophylaxis of gout.
Med Lett Drugs Ther. 2016 Jan 4;58(1485):5-6 |  Show IntroductionHide Introduction